Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 17 Apr 2026 for Whitehawk Therapeutics, Inc., €252k. Read the official filing
Filing timeline
BuySaleScott M. Giacobello
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Scott M. Giacobello: trading record in brief
Scott M. Giacobello, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Whitehawk Therapeutics, Inc. and GW Pharmaceuticals PLC. Over a trading history stretching from 5 May 2021 to 16 April 2026, the count stands at 7 filings.
Sales make up the whole of the open-market record (2 sales, €748k). Outside the open market, there are 1 share grant and 3 option exercises. 2026 to date brings no purchases and 2 sales.
On 17 April 2026 came the latest disclosure, an open-market sale for €252k in Whitehawk Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott M. Giacobello
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
77,000 shares@ US$3.8633.6% of flowCommon StockSEC:0001754154-26-000010:0
141,600 shares@ US$4.1366.4% of flowCommon StockSEC:0001754154-26-000010:1
473,902 sharesCommon StockSEC:0001754154-26-000005:0
6,750 sharesCommon StockSEC:0001754154-26-000002:0
6,750 sharesCommon StockSEC:0001415889-25-006318:0
20,000 shares@ US$12.50100.0% of flowCommon StockSEC:0001209191-22-051388:0
165,108 sharesOrdinary SharesSEC:0000899243-21-018661:0
7 of 7 declarations
